| Measurement of c-erbB-2 proteins in sera from patients with carcinomas and in breast tumor tissue cytosols: correlation with serum tumor markers and membrane-bound oncoprotein. | breast, |
| Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu. | breast,ovarian, |
| HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. | HNSC, |
| The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a review. | breast, |
| c-erbB-2 oncoprotein in relation to DNA ploidy and prognosis in colorectal adenocarcinoma. | colorectal, |
| Level of c-erbB-2 oncoprotein in the homogenate of malignant and benign breast tumor samples. | breast, |
| ErbB-2 oncoprotein overexpression in breast carcinoma: inverse correlation with biochemically- and immunohistochemically-determined hormone receptors. | breast, |
| Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry. | breast, |
| C-erbB-2 oncogene product expression depends on tumour type and is related to oestrogen receptor and lymph node status in human breast carcinoma. | breast, |
| Amplification of HER-2(erbB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients. | breast, |
| Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene. | ovarian, |
| Role of DNA ploidy and ERB-B2 oncogene expression in the prognosis of endometrial carcinoma. | endometrial, |
| Amplification of the C-erbB-2(HER-2/neu) proto-oncogene in ovarian carcinomas. | ovarian, |
| c-erbB-2 oncogene expression in Stage I epithelial ovarian cancer. | ovarian, |
| Expression of p53 tumor suppressor gene, oncoprotein c-erbB-2, cellular proliferation and differentiation in malignant and benign pancreatic lesions. | pancreatic, |
| [The relation between prognosis and amplification of the c-erB-2 (HER-2/neu) proto-oncogene in ovarian carcinomas]. | ovarian, |
| Immunocytochemical staining of c-erb B-2 oncogene in fine-needle aspirates of breast carcinoma: a comparison with tissue sections and other breast cancer prognostic factors. | breast, |
| c-erbB-2/neu oncogene and Ki-67 analysis in the assessment of palatal salivary gland neoplasms. | neoplasm, |
| Occurrence of microsatellite instability in gastric carcinoma is associated with enhanced expression of erbB-2 oncoprotein. | gastric, |
| [Expression of the p185neu oncoprotein indicates an unfavorable prognosis in small, node negative breast cancer without systemic adjuvant treatment (T1N0)]. | breast, |